2021-11-09T13:08:39-06:00 2020-12-31 561445619 NEAL BRADSHER & TAYLOR PA 4721 EMPEROR BOULEVARD SUITE 130 DURHAM NC 27703 990 2020-01-01 812849764 GLIOBLASTOMA FOUNDATION INC GLIO 9194021775 2451 CROASDAILE FARM PARKWAY NO 1 DURHAM NC 27705 MADAN KWATRA PHD SECRETARY/TREASURER 9194021775 2021-09-17 1 MADAN KWATRA PHD 999009999 MICHAEL CLONCH P01380043 9194893369 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z MADAN KWATRA PHD 3512 LOCHNORA PARKWAY DURHAM NC 27705 3535681 0 X WWW.GLIOBLASTOMAFOUNDATION.ORG X 2016 NC TO TRANSFORM THE STANDARD OF CARE FOR GLIOBASTOMA BY SUPPORTING THE DEVELOPMENT OF TARGETED THERAPIES THAT WORK FOR ALL GLIOBLASTOMA PATIENTS. TO ALSO SUPPORT AWARENESS AND EDUCATION EFFORTS FOR GLIOBLASTOMA AS WELL AS PROVIDING PATIENT RESOURCES FOR INDIVIDUALS DIAGNOSED WITH GLIOBLASTOMA. 3 0 1 10 0 0 448677 842093 0 0 0 115774 0 805 448677 958672 30000 47900 0 0 121463 175692 0 0 17289 145128 100336 296591 323928 152086 634744 455940 1140681 0 0 455940 1140681 X TO TRANSFORM THE STANDARD OF CARE FOR GLIOBASTOMA BY SUPPORTING THE DEVELOPMENT OF TARGETED THERAPIES THAT WORK FOR ALL GLIOBLASTOMA PATIENTS. TO ALSO SUPPORT AWARENESS AND EDUCATION EFFORTS FOR GLIOBLASTOMA AS WELL AS PROVIDING PATIENT RESOURCES FOR INDIVIDUALS DIAGNOSED WITH GLIOBLASTOMA. 0 0 277889 47900 805 OVER THE PAST FIVE YEARS SINCE ITS INCEPTION, THE GLIOBLASTOMA FOUNDATION HAS PROVIDED FUNDING FOR SEVERAL NEW DRUGS AND OTHER INNOVATIVE THERAPIES TO EXTEND SURVIVAL AN IMPROVE PATIENT QUALITY OF LIFE FOR THOSE IMPACTED BY GLIOBLASTOMA. THE GLIOBLASTOMA FOUNDATION IS THE ONE AND ONLY NATIONAL NON PROFIT COMMITTED TO FUNDING NEW, MORE EFFECTIVE THERAPIES FOR GLIOBLASTOMA THAT WILL WORK FOR ALL PATIENTS. OVER ITS HISTORY, THE GLIOBLASTOMA FOUNDATION HAS FUNDED TRIALS FOR THE FOLLOWING DRUGS FOR GLIOBLASTOMA INCLUDING MEBENDAZOLE AT JOHNS HOPKINS UNIVERSITY AND HSP-90 INHIBITOR DRUGS AT OHIO STATE UNIVERSITY.ONE OF THE GLIOBLASTOMA FOUNDATION'S KEYNOTE INITIATIVES IS THE OSIMERTINIB TRIAL. THE DRUG OSIMERTINIB HAS BEEN SHOWN TO BE EFFECTIVE AT EXTENDING LIFE FOR A SUBSTANTIAL SUBSET OF GLIOBLASTOMA PATIENTS. THE GLIOBLASTOMA FOUNDATION HAS WORKED TO MAKE THIS DRUG AVAILABLE FOR ALL GLIOBLASTOMA PATIENTS AND IS CURRENTLY FUNDING A MULTI-CENTER, NATIONAL CLINICAL TRIAL TO GET THIS DRUG APPROVED FOR GLIOBLASTOMA PATIENTS. STUDY SITES FUNDED BY THE GLIOBLASTOMA FOUNDATION INCLUDE UNIVERSITY OF PENNSYLVANIA, WAKE FOREST UNIVERSITY, JOHNS HOPKINS UNIVERSITY, AND OTHERS.THE GLIOBLASTOMA FOUNDATION IS THE NATIONAL LEADER IN FUNDING NEW THERAPIES THAT WILL TRANSFORM GLIOBLASTOMA FROM TERMINAL TO TREATABLE.IN ADDITION TO PROVIDING FUNDING FOR THE OSIMERTINIB TRIAL, THE GLIOBLASTOMA FOUNDATION IS ALSO FUNDING THE ADVANCEMENT OF NEUROSURGICAL TECHNIQUES TO IMPROVE PATIENT SURVIVAL FOR INOPERABLE GLIOBLASTOMAS. OUR STUDY TO IMPROVE SURGICAL TECHNIQUES FOR BRAINSTEM GLIOBLASTOMA WILL RESULT IN PROLONGED SURVIVAL FOR PATIENTS WITH THIS DEADLY TYPE OF GLIOBLASTOMA. SINCE ITS INCEPTION IN 2016, THE GLIOBLASTOMA FOUNDATION HAS PLACED A STRONG FOCUS ON IMPROVING NEUROSURGICAL TECHNIQUES FOR GLIOBLASTOMA. AS PART OF OUR MULTI-PROLONGED, ONE-OF-A KIND NEUROSURGERY RESEARCH AWARD NAMED AFTER THE LATE RUSH DRUMMER NEIL PEART, WE ARE FUNDING NEUROSURGERY RESEARCH AT SEVERAL LEADING RESEARCH CENTERS AROUND THE COUNTRY INCLUDING THE UNIVERSITY OF PITTSBURGH.BY LEVERAGING ITS SCIENTIFIC EXPERTISE AND LEADERSHIP, THE GLIOBLASTOMA FOUNDATION IS UNIQUELY POSITIONED TO IDENTIFY THE BEST NEW THERAPIES WITH THE GREATEST LIKELIHOOD OF SUCCESS FOR IMPROVING PATIENT SURVIVAL AND ULTIMATELY LEADING TO A CURE FOR THIS DEADLY DISEASE.THE GLIOBLASTOMA FOUNDATION IS A TRUSTED SOURCE OF INFORMATION FOR PATIENTS AND FAMILIES IMPACTED BY GLIOBLASTOMA. THROUGH ITS NATIONALLY RECOGNIZED PATIENT SUPPORT PROGRAMS THE GLIOBLASTOMA FOUNDATION PROVIDES IMPORTANT RESOURCES FOR PATIENTS DIAGNOSED WITH GLIOBLASTOMA, INCLUDING CLINICAL TRIALS MATCHING LED BY A CLINICAL STAFF OF PHYSICIANS, RESEARCHERS, AND PHARMACISTS. THE GLIOBLASTOMA FOUNDATION ALSO LEVERAGES ITS SCIENTIFIC AND CLINICAL RESOURCES TO CONNECT PATIENTS WITH SECOND OPINIONS AT LEADING MEDICAL CENTERS ACROSS THE NATION. THE GLIOBLASTOMA FOUNDATION PUBLISHES AND PERIODICALLY UPDATES CLINICAL RESOURCES FOR PATIENTS AND CAREGIVERS THAT HAVE COME TO BE A TRUSTED SOURCE OF INFORMATION FOR THOSE BATTLING GLIOBLASTOMA.GLIOBLASTOMA IS A RARE, DEADLY GRADE 4 BRAIN TUMOR THAT IS TERMINAL 95% OF THE TIME. THE GLIOBLASTOMA FOUNDATION HAS WORKED TO ENSURE THAT EVERYONE KNOWS WHAT A SERIOUS CONDITION GLIOBLASTOMA IS. THROUGH ITS LONG-STANDING NATIONAL PARTNERSHIP WITH THE LOS ANGELES MARATHON, THE GLIOBLASTOMA FOUNDATION HAS HELPED RAISE AWARENESS OF GLIOBLASTOMA. THE GLIOBLASTOMA FOUNDATION ALSO RAISES AWARENESS THROUGH ANNUAL KEYNOTE EVENTS LIKE OUR "GLIOBLASTOMA AWARENESS GALA" HELD EACH YEAR IN WASHINGTON, DC AND OUR "GET UP FOR GLIOBLASTOMA" HALF MARATHON HELD EACH MAY. 277889 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 0 0 X MADAN KWATRA PHD 9194021775 2451 CROASDAILE FARM PAKWAY SUITE DURHAM NC 27705 NEELAM KWATRA MA PRESIDENT 4.00 X X 0 0 0 MADAN KWATRA PHD SECRETARY/TREASURER 4.00 X X 0 0 0 GITA KWATRA PHARMD MBA CEO 40.00 X X 143627 0 11760 143627 0 11760 1 0 1 0 0 842093 842093 4227 4227 2688556 2577009 111547 111547 111547 REIMBURSEMENT 900099 805 805 805 958672 805 0 115774 47900 47900 158317 142485 7916 7916 6275 6275 11100 9990 555 555 3413 3413 1826 1826 41897 37707 2095 2095 30360 14498 11042 4820 7617 6855 381 381 15223 12179 1522 1522 323928 277889 28750 17289 455940 514926 625755 455940 1140681 0 0 X 455940 1140681 455940 1140681 455940 1140681 634744 49997 0 X 0 0 0 X 11749 48380 313448 448677 842093 1664347 11749 48380 313448 448677 842093 1664347 1664347 115774 115774 1780121 0.93500 0.98960 X 0 ETRADE 625755 F 625755 1 UNIVERISTY OF PITTSBURGH MEDICAL CENTER 200 LOTHROP STREET PITTSBURGH PA 15213 251423657 5000 FMV GLIOBLASTMA RESEREACH UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET 5TH FLOOR PHILADELPHIA PA 19104 231352685 10000 FMV GLIOBLASTMA RESEREACH DUKE UNIVERSITY HOSPITAL PO BOX 90581 DURHAM NC 27708 560532129 20000 FMV GLIOBLASTMA RESEREACH WAKE FOREST BAPTIST HEALTH MEDICAL CENTER BLVD WINSTONSALEM NC 27157 510190238 10000 FMV GLIOBLASTMA RESEREACH X 0 0 0 0 0 0 0 0 0 GITA KWATRA PHARMD MBA CEO 143627 0 0 0 0 0 7006 0 4754 0 155387 0 0 0 GITA KWATRA PHARMD MBA FAMILY MEMBER ARE ON THE BOARD 155387 GITA IS A SALARIED EMPLOYEE OF THE ORGANIZATION 0 FORM 990, PART VI, SECTION A, LINE 2 ALL MEMBERS OF THE BOARD ARE FAMILY MEMBERS. FORM 990, PART VI, SECTION A, LINE 8B THE ORGANIZATION DID NOT HAVE COMMITTEES. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS AVAILABLE TO THE ORGANIZATION'S ENTIRE GOVERNING BODY AND BOARD MEMBERS. FORM 990 IS REVIEWED BY THE ORGANIZATION'S PRESIDENT AND TREASURER BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EMPLOYEES AND DIRECTORS ARE REQUIRED TO DISCLOSE CONFLICT OF INTERESTS WHEN THEY ARISE AND ARE REQUIRED TO FILE AN ANNUAL DISCLOSURE FORM. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION IS IN ACCORDANCE WITH NATIONAL STANDARDS FOR OTHER HEALTHCARE NONPROFITS FORM 990, PART VI, SECTION C, LINE 18 TAX RETURNS ARE AVAILABLE FOR PUBLIC INSPECTION ON THE GUIDESTAR WEBSITE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION CURRENTLY DOES NOT MAKE A CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC.